Company profile for Statera Biopharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Statera Biopharma’s foundation is based on restoring immune health through the leveraging of complex, pleiotropic beneficial effects. At Statera, we embrace the idea that beneficial and safe drugs act as natural analogs in a paracrine fashion, as well as a trans-activator to resolve disease and elicit homeostasis. Statera is going to change the way people think about immunotherapy. Protective immunity and resolution to he...
Statera Biopharma’s foundation is based on restoring immune health through the leveraging of complex, pleiotropic beneficial effects. At Statera, we embrace the idea that beneficial and safe drugs act as natural analogs in a paracrine fashion, as well as a trans-activator to resolve disease and elicit homeostasis. Statera is going to change the way people think about immunotherapy. Protective immunity and resolution to health (homeostasis) is orchestrated in parallel by multiple cell subsets, surface receptors, soluble factors and intracellular pathways.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Fort Collins, Colorado
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2023/04/20/2651112/0/en/Biostax-Corp-and-Statera-Biopharma-Inc-reach-mutually-beneficial-dispute-settlement-and-amended-license-agreement-providing-clearer-clinical-and-commercial-pathways-for-both-compan.html

GLOBENEWSWIRE
20 Apr 2023

https://www.globenewswire.com/news-release/2023/03/15/2627590/0/en/Statera-Biopharma-Signs-Letter-of-Intent-for-Merger-with-Worksite-Labs.html

GLOBENEWSWIRE
15 Mar 2023

https://www.accesswire.com/722713/Statera-Biopharma-Receives-Positive-Nasdaq-Listing-Determination

ACCESSWIRE
27 Oct 2022

https://www.accesswire.com/721696/Statera-Biopharma-Files-Form-10-Q-and-Reaches-Agreement-with-Silverback-Capital-and-AVOF

ACCESSWIRE
21 Oct 2022

https://www.accesswire.com/720710/Statera-Biopharma-Announces-Signing-of-a-Binding-MOU-with-Holobeam-Technologies-to-Gain-Access-to-Holobeams-Disruptive-Diagnostic-Imaging-and-Therapeutic-Technology-for-Cancer-Patients

ACCESSWIRE
17 Oct 2022

https://www.accesswire.com/715457/Statera-Biopharma-Receives-Nasdaq-Listing-Determination-Hearing-Requested-to-Address-Filing-Delinquency

ACCESSWIRE
09 Sep 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty